logo
Sign in

NAGE Stock Price, Chart, Stats & News

Niagen Bioscience Inc
Save

Niagen Bioscience Inc (NAGE) does not currently pay a dividend.

252.47M
Market cap
19.81x
Current P/E
22.37x
Forward P/E

NAGE chart

1M
3M
1Y
5Y
Loading chart...

Fundamentals

Gross margin
64.28%
Operating margin
11.05%
Pretax margin
14.06%
Net margin
13.43%
Effective tax rate
4.45%
ROA
16.34%
ROE
26.06%
D/E
0.04x
Interest coverage ratio

NAGE valuation

P/E
19.81x
P/S
2.60x
P/B
4.33x
P/CF
24.66x
P/FCF
25.56x
P/OCF
24.66x
PEG
-1.24x
EV multiple
23.93x

About

Niagen Bioscience, Inc. operates as a bioscience company engages in developing healthy aging products. The company operates through Consumer products; Ingredients; and Pharmaceutical Segments. It provides finished dietary supplement products that contain its proprietary ingredients directly to consumers and distributors; nicotinamide adenine dinucleotide (NAD+), an essential coenzyme that regulates cellular metabolism; and develops and commercializes proprietary-based ingredient technologies, including food-grade, Niagen, and pharmaceutical-grade Niagen and supplies these ingredients as raw materials to the manufacturers of consumer products.

Similar securities

Based on sector and market capitalization

Report issue